Abstract
This study explores the drug use characteristics and underlying logic of Professor Yin Kejing, a master of Traditional Chinese Medicine (TCM), in treating mammary hyperplasia (MH). By analyzing 80 clinical prescriptions using Excel-based databases, association rule mining, and cluster analysis, the research identifies core herbal combinations and pharmacological properties. Results indicate that Astragalus membranaceus (Huangqi) is the foundational herb, with a primary focus on the liver meridian and a "bitter-warm" therapeutic strategy. Three distinct herbal clusters were identified, providing a standardized framework for treating MH through Qi activation and blood stasis removal.
Introduction
Mammary hyperplasia (MH) is a prevalent benign breast condition, affecting up to 75% of women in certain clinical populations. Characterized by pain and physical masses, it carries a significant risk of malignant transformation if left untreated. In TCM, MH is typically attributed to "liver qi depression" and "blood stasis." However, the complexity of master-level prescriptions often obscures the underlying therapeutic "law." This paper utilizes data mining to decode the clinical expertise of Professor Yin Kejing, bridging the gap between traditional intuition and evidence-based standardization.
Methodology
The researchers conducted a retrospective analysis of 80 clinical prescriptions collected between October and December 2020 at the Second Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine. The dataset involved 170 unique herbs and 1,784 individual uses.
Data processing involved:
- Frequency Analysis: Identifying the most common herbs, "Four Qi" (temperature), "Five Flavors," and "Meridian Tropism."
- Association Rule Mining: Using Weka 3.6.9 and SPSS Modeler to identify high-confidence herbal pairings (minimum 80% confidence).
- Cluster Analysis: Utilizing dendrograms to group herbs into synergistic clusters.
Results and Analysis
Core Herbal Properties and Tropism
The analysis revealed a strong preference for herbs targeting the Foot Yin Liver Meridian (1,040 instances), reinforcing the TCM link between breast health and liver function. The dominant therapeutic properties were "Bitter" flavors (32.75%) and "Warm" temperatures (46.24%), suggesting a strategy of aggressively breaking down masses while invigorating circulation.
Network Association Mapping
Astragalus membranaceus (Huangqi) appeared in 100% of the prescriptions, serving as the essential "Qi-supplementing" foundation. The network diagram illustrates the high-density associations between Huangqi and other core herbs like Radix Paeoniae Alba and Angelica sinensis.
Cluster Analysis and Synergistic Groups
Cluster analysis identified three primary "new combinations" that represent the core of Professor Yin’s treatment logic:
- Cluster 1: Focuses on supplementing Qi and nourishing blood (Astragalus + Radix Paeoniae).
- Cluster 2: Focuses on resolving phlegm and relieving pain (White mustard + Corydalis).
- Cluster 3: Focuses on moving Qi and breaking stasis (Curcuma + Chimonanthus).
Discussion and Conclusion
The data mining results suggest that Professor Yin’s "Drug Use Law" for mammary hyperplasia is centered on the principle of "treating both specimens"—simultaneously addressing the root cause (Qi deficiency) and the manifestation (blood stasis and masses). By supplementing Qi with Huangqi, the "pushing" force of the blood is increased, allowing secondary herbs to effectively resolve stasis in the liver meridian.
While the sample size of 80 cases is relatively small, the high confidence levels in association rules (such as the 100% confidence between Wintersweet Flower and Curcuma) provide a robust starting point for clinical standardization. Future work should correlate these herbal clusters with specific patient outcomes to verify clinical efficacy in controlled trials.
Summary updated